Psychiatr. praxi. 2020;21(2):74-77 | DOI: 10.36290/psy.2020.013

Schizo-obsessive symptoms

MUDr. Kryštof Kantor, prof. MUDr. Klára Látalová, Ph.D.
Klinika psychiatrie, Fakultní nemocnice Olomouc a Lékařská fakulta, Univerzita Palackého Olomouc

Obsessive compulsive disorder is among the comorbid disorders in schizophrenia. Although these two disorders form independent diagnostic categories, their characteristics show similarity to one another and their symptoms may also overlap. Obsessive compulsive disorder is expected to occur in up to 12 % of patients with schizophrenia. This knowledge leads to suggestions of the category of schizo-obsessive disorders and the definition of schizo-obsessive disorder as aseparate unit showing differences from both schizophrenia and obsessive compulsive disorder. The clinical significance of schizo-obsessive symptoms can be described from 3 perspectives: Obsessive-compulsive symptoms can precede psychosis and thus be seen as its prodroms. Obsessive-compulsive symptoms co-occuring with schizophrenia can cause diagnostic complications and negatively affect the prognosis of the disease. Obsessive compulsive symptoms may also be induced by antipsychotics, particularly clozapine, olanzapine and risperidone. This also complicates the therapeutic approach to schizoobsedant disorder.

Keywords: schizophrenia, obsesive-compulsive disorder, comorbidity, treatment, course.

Published: June 29, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kantor K, Látalová K. Schizo-obsessive symptoms. Psychiatr. praxi. 2020;21(2):74-77. doi: 10.36290/psy.2020.013.
Download citation

References

  1. Tezenas du Montcel C, Pelissolo A, Schürhoff F. Pignon B. Obsessive‑Compulsive Symptoms in Schizophrenia: an Up‑To‑Date Review of Literature. Curr Psychiatry Rep. 2019; 21: 64. Go to original source... Go to PubMed...
  2. Poyurovsky M, Zohar J, Glick I, Koran LM, Weizman R, Tandon R, Weizman A. Obsessive‑compulsive symptoms in schizophrenia: implications for future psychiatric classifications. Comprehensive Psychiatry. 2012; 53(5), 480-483. Go to original source... Go to PubMed...
  3. Naguy A. Schizo‑obsessive disorder: A clinical quagmire! Asian Journal of Psychiatry. 2019; 46, 9-10. Go to original source... Go to PubMed...
  4. Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy MA. How prevalent are anxiety disorders in schizophrenia? A meta‑analysis and critical review on a significant association. Schizophr Bull. 2011; 37: 811-821. Go to original source... Go to PubMed...
  5. Swets M, Dekker J, van Emmerik‑van Oortmerssen K, Smid GE, et al. The obsessive compulsive spectrum in schizophrenia, a meta‑analysis and meta‑regression exploring prevalence rates. Schizophr Res. 2014; 152: 458-468. Go to original source... Go to PubMed...
  6. Cederlöf M, Lichtenstein P, Larsson H, et al. Obsessive‑compulsive disorder, psychosis, and bipolarity: a longitudinal cohort and multigenerational family study. Schizophr Bull. 2015; 41: 1076-1083. 14. Go to original source... Go to PubMed...
  7. Meier SM, Petersen L, Pedersen MG, et al. Obsessive‑compulsive disorder as a risk factor for schizophrenia: a nationwide study. JAMA Psychiatry. 2014; 71: 1215-1221. Go to original source... Go to PubMed...
  8. Oulis P, Konstantakopoulos G, Lykouras L, Michalopoulou PG. Differential diagnosis of obsessive‑compulsive symptoms from delusions in schizophrenia: A phenomenological approach. World Journal of Psychiatry 2013; 3(3), 50. Go to original source... Go to PubMed...
  9. Scotti-Muzzi E, Saide OL. Transition from Obsession to Delusion in Schizo‑obsessive Disorder: A Case Report and Literature Overview. Innov Clin Neurosci. 2018; 15(7-8): 23-26.
  10. Center for Behavioral Health Statistics and Quality. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Rockville, MD. 2016
  11. Ganos C, Kassavetis P, Cerdan M, et al. Revisiting the Syndrome of "Obsessional Slowness". Mov Disord Clin Pract. 2015; 2: 163-169. Go to original source... Go to PubMed...
  12. Poyurovsky M, Koran L. Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. Journal of Psychiatric Research. 2005; 39(4), 399-408. Go to original source... Go to PubMed...
  13. Scotti‑Muzzi E, Saide O. Schizo‑obsessive spectrum disorders: An update. CNS Spectrums. 2017; 22(3), 258-272. Go to original source... Go to PubMed...
  14. Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive‑compulsive disorder in schizophrenia: is there evidence for a schizo‑obsessive subtype of schizophrenia? J Psychiatry Neurosci JPN. 2005; 30: 187-193.
  15. Cunill R, Castells X, Simeon D. Relationships between obsessivecompulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta‑analysis. J Clin Psychiatry. 2009; 70: 70-82. Go to original source... Go to PubMed...
  16. Zink M. Comorbid obsessive‑compulsive symptoms in schizophrenia: insight into pathomechanisms facilitates treatment. Adv Med. 2014; 2014: 317980. Go to original source... Go to PubMed...
  17. Englisch S, Esslinger C, Inta D, et al. Clozapine‑Induced Obsessive‑Compulsive Syndromes Improve in Combination With Aripiprazole. Clinical Neuropharmacology. 2009; 32(4), 227-229. Go to original source... Go to PubMed...
  18. Stryjer R, Dambinsky Y, Timinsky I, et al. Escitalopram in the treatment of patients with schizophrenia and obsessive‑compulsive disorder: an open‑label, prospective study. Int Clin Psychopharmacol. 2013; 28: 96-98. Go to original source... Go to PubMed...
  19. Hanisch F, Friedemann J, Piro J, Gutmann P. Maintenance electroconvulsive therapy for comorbid pharmacotherapy‑refractory obsessive‑compulsive and schizoaffective disorder. Eur J Med Res. 2009; 14: 367-368. Go to original source... Go to PubMed...
  20. Tundo A, Necci R. Cognitive‑behavioural therapy for obsessive‑compulsive disorder co‑occurring with psychosis: systematic review of evidence. World J Psychiatry. 2016; 6: 449-455. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.